Literature DB >> 11725119

Transcriptional Silencing of Retroviral Vectors.

A.H. Lund1, M. Duch, F.S. Pedersen.   

Abstract

Although retroviral vector systems have been found to efficiently transduce a variety of cell types in vitro, the use of vectors based on murine leukemia virus in preclinical models of somatic gene therapy has led to the identification of transcriptional silencing in vivo as an important problem. Extinction of long-term vector expression has been observed after implantation of transduced hematopoietic cells as well as fibroblasts, myoblasts and hepatocytes. Here we review the influence of vector structure, integration site and cell type on transcriptional silencing. While down-regulation of proviral transcription is known from a number of cellular and animal models, major insight has been gained from studies in the germ line and embryonal cells of the mouse. Key elements for the transfer and expression of retroviral vectors, such as the viral transcriptional enhancer and the binding site for the tRNA primer for reverse transcription may have a major influence on transcriptional silencing. Alterations of these elements of the vector backbone as well as the use of internal promoter elements from housekeeping genes may contribute to reduce transcriptional silencing. The use of cell culture and animal models in the testing and improvement of vector design is discussed. Copyright 1996 S. Karger AG, Basel

Entities:  

Year:  1996        PMID: 11725119     DOI: 10.1007/bf02258042

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  13 in total

1.  Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.

Authors:  S Ethelberg; J Lovmand; J Schmidt; A Luz; F S Pedersen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells.

Authors:  C Fernex; P Dubreuil; P Mannoni; C Bagnis
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Abundant defective viral particles budding from microglia in the course of retroviral spongiform encephalopathy.

Authors:  R Hansen; S Czub; E Werder; J Herold; G Gosztonyi; H Gelderblom; S Schimmer; S Mazgareanu; V ter Meulen; M Czub
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells.

Authors:  P B Robbins; X J Yu; D M Skelton; K A Pepper; R M Wasserman; L Zhu; D B Kohn
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Streamlined platform for short hairpin RNA interference and transgenesis in cultured mammalian cells.

Authors:  Piyush Khandelia; Karen Yap; Eugene V Makeyev
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

6.  Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.

Authors:  P B Robbins; D C Skelton; X J Yu; S Halene; E H Leonard; D B Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo.

Authors:  M P Rubinstein; M L Salem; A N Kadima; C L Nguyen; W E Gillanders; M I Nishimura; D J Cole
Journal:  Cancer Gene Ther       Date:  2008-08-08       Impact factor: 5.987

Review 8.  Accelerating cancer modeling with RNAi and nongermline genetically engineered mouse models.

Authors:  Geulah Livshits; Scott W Lowe
Journal:  Cold Spring Harb Protoc       Date:  2013-11-01

9.  Factors determining the risk of inadvertent retroviral transduction of male germ cells after in utero gene transfer in sheep.

Authors:  Paul J Park; Evan Colletti; Ferhat Ozturk; Josh A Wood; Joe Tellez; Graça Almeida-Porada; Christopher Porada
Journal:  Hum Gene Ther       Date:  2009-03       Impact factor: 5.695

10.  Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi.

Authors:  Johannes Zuber; Katherine McJunkin; Christof Fellmann; Lukas E Dow; Meredith J Taylor; Gregory J Hannon; Scott W Lowe
Journal:  Nat Biotechnol       Date:  2010-12-05       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.